Armstrong Advisory Group’s Alkermes ALKS Stock Holding History

Armstrong Advisory Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$28.6K	–	942
2025 Q2	$28.6K	Buy	+1,000	New	+$29.8K	﹤0.01%	484

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armstrong Advisory Group's ALKS Position: Q3 2025 in Review

Armstrong Advisory Group sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 1,000 shares — an estimated $28.6K sold.

Armstrong Advisory Group first reported a position in ALKS in Q2 2025 and held it in 1 quarter. The position peaked at $28.6K in Q2 2025. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

Armstrong Advisory Group reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
Armstrong Advisory Group sold 1,000 Alkermes shares in Q3 2025, an estimated $28.6K.
Armstrong Advisory Group first reported a position in Alkermes in Q2 2025 and held it in 1 quarter.
Armstrong Advisory Group's Alkermes position peaked at $28.6K in Q2 2025.
358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on Armstrong Advisory Group's 13F filing for Q3 2025, filed 8 Oct 2025.